3rd Antigen-Specific Immune Tolerance Drug Development

  • 25-27 Feb 2020
  • Colonnade Hotel, Boston, MA, United States

Description

The 3rd Antigen-Specific Immune Tolerance Drug Development is dedicated to safe and effective antigen-specific immune tolerance therapies.

The 3rd Antigen-Specific Immune Tolerance Drug Development covers topics such as:

  • Analyzing the Scope & Strategies to Antigen-Specific Immune Tolerance
  • Dynamics of Underlying Causes & Current Understandings of Autoimmunity
  • Improving the Pre-Clinical Predictability of Antigen-Specific Immune Tolerance Therapies
  • Identification, Validation & Targeting of Specific Antigens for Immune Tolerance Therapies
  • Optimizing Clinical Development & Paving the Future of Antigen-Specific Immune Tolerance Therapies
  • Surging Translational Potentials of Pre-Clinical Antigen-Specific Therapies
  • Commercialization: Future Proofing Immune Tolerance Therapies for Patients

The 3rd Antigen-Specific Immune Tolerance Drug Development will be held in Boston, MA, United States on 25-27 Feb 2020.

Venue

Colonnade Hotel
120 Huntington Avenue ,
Boston,
Massachusetts,
United States
  View all Hotels near Venue

More Details

998-2999 US Dollar
No exhibition
Hanson Wade

Future Events

  • 3rd Antigen-Specific Immune Tolerance Drug Development - 25-27 Feb 2020, Colonnade Hotel, Boston, MA, United States (81461)
  • 4th Antigen-Specific Immune Tolerance Drug Development - 2021, Boston, MA, United States (73896)

Past Events

  • 2nd Antigen-Specific Immune Tolerance Drug Development Summit 2019 - 26-28 Mar 2019, Wyndham Boston Beacon Hill, Boston, MA, United States (81459)

Important

Please, check the official conference website for possible changes, before you make any traveling arrangements

Prices are for evaluation only.

Other Events with Similar Categories

Featured Conferences & Exhibitions